Characterization of magnesium requirement of human 5'-tyrosyl DNA phosphodiesterase mediated reaction

被引:11
作者
Sanjay Adhikari
Soumendra K Karmahapatra
Tejaswita M Karve
Sanjona Bandyopadhyay
Jordan Woodrick
Praveen V Manthena
Eric Glasgow
Stephen Byers
Tapas Saha
Aykut Uren
机构
[1] Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington
[2] Department of Biochemistry and Molecular and Cellular Biology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington
基金
美国国家卫生研究院;
关键词
Product Formation; Cold Ringer; Phosphotyrosyl; Excess EDTA; Active Site Tyrosine;
D O I
10.1186/1756-0500-5-134
中图分类号
学科分类号
摘要
Background: Topo-poisons can produce an enzyme-DNA complex linked by a 3'- or 5'-phosphotyrosyl covalent bond. 3'-phosphotyrosyl bonds can be repaired by tyrosyl DNA phosphodiesterase-1 (TDP1), an enzyme known for years, but a complementary human enzyme 5'-tyrosyl DNA phosphodiesterase (hTDP2) that cleaves 5'-phosphotyrosyl bonds has been reported only recently. Although hTDP2 possesses both 3'- and 5'- tyrosyl DNA phosphodiesterase activity, the role of Mg 2+ in its activity was not studied in sufficient details. Results: In this study we showed that purified hTDP2 does not exhibit any 5'-phosphotyrosyl phosphodiesterase activity in the absence of Mg 2+/Mn 2+, and that neither Zn 2+ or nor Ca 2+ can activate hTDP2. Mg 2+ also controls 3'-phosphotyrosyl activity of TDP2. In MCF-7 cell extracts and de-yolked zebrafish embryo extracts, Mg 2+ controlled 5'-phosphotyrosyl activity. This study also showed that there is an optimal Mg 2+ concentration above which it is inhibitory for hTDP2 activity. Conclusion: These results altogether reveal the optimal Mg 2+ requirement in hTDP2 mediated reaction. © 2011 Adhikari et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 28 条
[1]  
Wang J.C., Cellular roles of DNA topoisomerases: A molecular perspective, Nature Reviews Molecular Cell Biology, 3, 6, pp. 430-440, (2002)
[2]  
Nitiss J.L., Investigating the biological functions of DNA topoisomerases in eukaryotic cells, Biochimica et Biophysica Acta - Gene Structure and Expression, 1400, 1-3, pp. 63-81, (1998)
[3]  
Dexheimer T.S., Antony S., Marchand C., Pommier Y., Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy, Anti-Cancer Agents in Medicinal Chemistry, 8, 4, pp. 381-389, (2008)
[4]  
Yang S.-W., Burgin Jr. A.B., Huizenga B.N., Robertson C.A., Yao K.C., Nash H.A., A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases, Proceedings of the National Academy of Sciences of the United States of America, 93, 21, pp. 11534-11539, (1996)
[5]  
Wang J.C., Moving one DNA double helix through another by a type II DNA topoisomerase: The story of a simple molecular machine, Quarterly Reviews of Biophysics, 31, 2, pp. 107-144, (1998)
[6]  
Corbett K.D., Berger J.M., Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases, Annual Review of Biophysics and Biomolecular Structure, 33, pp. 95-118, (2004)
[7]  
Nitiss J.L., Targeting DNA topoisomerase II in cancer chemotherapy, Nat Rev Cancer, 9, pp. 338-350, (2009)
[8]  
Bahmed K., Nitiss K.C., Nitiss J.L., UnTTrapping the ends: A new player in overcoming protein linked DNA damage, Cell Res, 20, pp. 22-123, (2010)
[9]  
Cortes Ledesma F., El Khamisy S.F., Zuma M.C., Osborn K., Caldecott K.W., A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage, Nature, 461, pp. 674-678, (2009)
[10]  
Zeng Z., Cortes-Ledesma F., El-Khamisy S.F., Caldecott K.W., TDP2/TTRAP Is the Major 5'-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II- induced DNA Damage, J Biol Chem, 286, pp. 403-409, (2011)